Rare diseases
Investigational molecules
Locations
Back to Hungary68 clinical trials in Torokbalint, Hungary across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
HungaryHungaryHungaryHungaryHungaryHungaryHungaryHungaryHungaryHungaryHungaryHungaryThe busiest research cities in the country
What the registry says about research in the country
Extensive clinical trials focusing on non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC), evaluating innovative combination therapies and immunotherapy approaches.
Multiple studies investigating targeted therapies for various stages of lung cancer, particularly focusing on patients with specific genetic markers and PD-L1 expression levels.
Research initiatives addressing chronic respiratory diseases, including asthma and chronic obstructive pulmonary disease (COPD), testing new therapeutic approaches.
Studies evaluating novel medications and combination therapies to improve patient outcomes in chronic respiratory conditions.
Cutting-edge research examining novel drug combinations and treatment approaches, including targeted therapies and immunotherapy agents.
Focus on developing personalized treatment approaches based on specific biomarkers and genetic profiles.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
